Epizyme, Inc. (EPZM) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Ibrahim_1 Ibrahim_1 09/02/2016 3 months $7.28 $11.10 +52.47% 52 Ended
Comments: It has strong support at about 7.15
laurvp laurvp 09/23/2015 1 month $19.53 $11.77 -39.73% 39 Ended
Hugo Pinto Hugo Pinto 04/09/2015 3 months $18.29 $24.27 +32.7% 32 Ended
Comments: Data on new targets and info on CELG collaboration
M.K. M.K. 03/13/2015 3 months $23.10 $18.84 -18.44% 18 Ended
Comments: Upcoming product launch won't be successful
Dragan Maksimovic Dragan Maksimovic 02/25/2015 3 months $23.27 $19.10 -17.92% -17 Ended
RskyBuziness RskyBuziness 06/30/2014 1 Year $31.12 $20.47 -34.22% -34 Ended
Comments: Lymphoma BioTech - clinical stage, big-upside when FDA apprv'd, Up 50+% YTD. Help them help you!

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.